Dishman Carbogen Amcis
Pharmaceuticals & Drugs
Dishman Carbogen Amcis Limited (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator
What GuideTrack tracks for Dishman Carbogen Amcis
Every earnings call is read for the annual guidance management gives — revenue growth, revenue in rupees, and margins — with the verbatim quote and who said it. When the year closes, each promise is scored against what was actually delivered. Calls processed so far: Q4FY26.
- The exact figure management guided, and the sentence they said it in
- Whether the number was later raised, lowered or quietly dropped
- What was delivered, and the achievement score for each year
- Quarterly on-track / at-risk / off-track updates through the year
GuideTrack is a research tool. Nothing here is investment advice or a recommendation to buy or sell Dishman Carbogen Amcis. Our extraction is AI-assisted and can make mistakes — always check the company's own filings.